High body mass index (BMI) ≥ 30 kg/m2 is associated with non-optimal perioperative consequences in women undergoing hysterectomy and is deemed a contraindication for non-descent vaginal hysterectomy (NDVH) by utmost gynecologic surgeons, is this contraindication authentic or assumed?
Objective
To estimate the influence of BMI on perioperative outcomes in patients who underwent NDVH for non-malignant uterine disorders.
Patients and Methods
This retrospective cohort involves 843 patients; 413 patients were non-obese (BMI < 30 kg/m2) and 430 patients were obese (BMI ≥ 30 kg/m2).
Results
BMI differed significantly between groups (27.4±6.7 vs. 38.6±11.6, P= 0.0001). Both groups also differed regarding age, parity, preoperative medical comorbidity including hypertension and diabetes mellites, American Society of Anesthesiologists physical status, and endometrial hyperplasia incidence (P |
